Simvastatin combined with antiviral therapy for hepatitis B cirrhosis with portal hypertension: A case report
For hepatitis B cirrhosis patients with portal hypertension who are intolerant to or have contraindications for carvedilol, simvastatin combined with antiviral therapy is a safe, effective alternative. It significantly reduces HVPG, improves liver stiffness, and causes no obvious adverse events.
Authors
- Wei Gou (ORCID: https://orcid.org/0009-0004-4405-3646)
- Haodong Zhang (ORCID: https://orcid.org/0009-0002-4718-6095)
- Xuefang Li (ORCID: https://orcid.org/0000-0001-7748-3563)
- Yong Zhou
- Zhensheng Liu
- Hui Wang
- Xiaolong Qi
- Jinjin Li
Institutions
- Zhongda Hospital Southeast University (CN)
- Qingdao Center of Resource Chemistry and New Materials (CN)
Publication Details
- Journal
- Medicine
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1097/md.0000000000046933
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00